日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis

一线治疗晚期肺肉瘤样癌的疗效:一项真实世界分析

Amrane, K; Cabarrou, B; Justeau, G; Schneider, S; Quantin, X; Falchero, L; Bigot, F; Ferrari, V; Guisier, F; Girard, N; Lena, H; Dansin, E; Madroszyk, A; Bizieux, A; Debieuvre, D; Perol, M; Simoneau, Y; Bosquet, L; Descourt, R; Chouaïd, C

Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study

Luribinectedin治疗广泛期小细胞肺癌:IFCT-2105 LURBICLIN研究简报

Girard, N; Guisier, F; Swalduz, A; Van Hulst, S; Pichon, E; Lavaud, P; Greillier, L; Tiotiu, A; Madroszyk, A; Bylicki, O; Canellas, A; Belmont, L; Zysman, M; Hauss, P-A; Godbert, B; Audigier-Valette, C; Lebreton, C; Morin, F; Westeel, V

Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records

免疫检查点抑制剂治疗期间的甲状腺功能异常与成人癌症患者总体生存率的提高相关:对 1385 份电子病历的数据挖掘

Beaufils, Mathilde; Amodru, Vincent; Tejeda, Manuel; Boher, Jean Marie; Zemmour, Christophe; Chanez, Brice; Chrétien, Anne Sophie; Gorvel, Laurent; Gravis, Gwenaelle; Bruyat, Damien; Mari, Roxane; Madroszyk, Anne; Cuny, Thomas; Gonçalves, Anthony; Lisberg, Aaron E; Olive, Daniel; Tassy, Louis; Castinetti, Frederic; Rochigneux, Philippe

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer

质谱流式细胞术揭示经典单核细胞、NK细胞和ICOS+ CD4+ T细胞与帕博利珠单抗治疗肺癌患者的疗效相关

Rochigneux, Philippe; Lisberg, Aaron; Garcia, Alejandro; Granjeaud, Samuel; Madroszyk, Anne; Fattori, Stéphane; Gonçalves, Anthony; Devillier, Raynier; Maby, Pauline; Salem, Nassim; Gorvel, Laurent; Chanez, Brice; Gukasyan, Jaklin; Carroll, James; Goldman, Jonathan; Chretien, Anne Sophie; Olive, Daniel; Garon, Edward B

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

晚期癌症的前瞻性高通量基因组分析:PERMED-01 临床试验结果

Bertucci, François; Gonçalves, Anthony; Guille, Arnaud; Adelaïde, José; Garnier, Séverine; Carbuccia, Nadine; Billon, Emilien; Finetti, Pascal; Sfumato, Patrick; Monneur, Audrey; Pécheux, Christophe; Khran, Martin; Brunelle, Serge; Mescam, Lenaïg; Thomassin-Piana, Jeanne; Poizat, Flora; Charafe-Jauffret, Emmanuelle; Turrini, Olivier; Lambaudie, Eric; Provansal, Magali; Extra, Jean-Marc; Madroszyk, Anne; Gilabert, Marine; Sabatier, Renaud; Vicier, Cécile; Mamessier, Emilie; Chabannon, Christian; Pakradouni, Jihane; Viens, Patrice; André, Fabrice; Gravis, Gwenaelle; Popovici, Cornel; Birnbaum, Daniel; Chaffanet, Max

Celiac Disease After Administration of Immune Checkpoint Inhibitors: A Case Report

免疫检查点抑制剂治疗后发生乳糜泻:病例报告

Leblanc, Julie; Hoibian, Solene; Boucraut, Agathe; Ratone, Jean-Philippe; Stoffaes, Louis; Dano, Domitille; Louvel-Perrot, Delphine; Chanez, Brice; Chretien, Anne-Sophie; Madroszyk, Anne; Rochigneux, Philippe

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

一项III期随机研究,比较卡铂、培美曲塞联合或不联合贝伐单抗,以及初始脑部放疗与“进展后”脑部放疗治疗晚期非鳞状非小细胞肺癌伴无症状脑转移的疗效。

Monnet, Isabelle; Vergnenègre, Alain; Robinet, Gilles; Berard, Henri; Lamy, Regine; Falchero, Lionel; Vieillot, Sabine; Schott, Roland; Ricordel, Charles; Chouabe, Stephane; Thomas, Pascal; Gervais, Radj; Madroszyk, Anne; Abdiche, Samir; Chiappa, Anne Marie; Greillier, Laurent; Decroisette, Chantal; Auliac, Jean Bernard; Chouaïd, Christos

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial

1260MO OSE-2101 在 HLA-A2+ 非小细胞肺癌 (NSCLC) 患者中免疫检查点抑制剂 (ICI) 治疗失败后的活性:III 期 ATALANTE-1 随机试验的第一阶段结果

Pradier, A; Mamez, A C; Stephan, C; Giannotti, F; Masouridi-Levrat, S; Wang, S; Morin, S; Neofytos, D; Vu, D L; Melotti, A; Arm, I; Eberhardt, C S; Tamburini, J; Kaiser, L; Chalandon, Y; Simonetta, F; Bakouny, Z; Grover, P; Labaki, C; Awosika, J; Gulati, S; Hsu, C-Y; Bilen, MA; Eton, O; Fecher, L; Hwang, C; Khan, H; McKay, RR; Ruiz, E; Weissmann, L; Thompson, MA; Shah, D; Warner, J; Shyr, Y; Choueiri, TK; Wise-Draper, T; Pacheco-Barcia, V; Sanchez, DA; Obispo, B; Quilez, A; Sesma, A; JimEnez Labaig, P; Paez, D; Quintanar Verduguez, T; Sánchez Cánovas, M; Tarazona, N; Fernandez Montes, A; Felip, E; Rodríguez-Lescure, A; Elez Fernandez, ME; Giaccone, G; Felip, E; Cobo, M; Campelo, R Garcia; DENIS, F; Quoix, E; Madroszyk, A; Debieuvre, D; Hilgers, W; Moran, T; Galetta, D; Romano, GD; Cappuzzo, F; Robinet, G; Masson, P; Viteri, S; Peled, N; Costantini, D; Dziadziuszko, R; Besse, B

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review

肺癌的药物治疗:免疫细胞能否预测治疗反应?一项系统性综述

Rochigneux, Philippe; Garcia, Alejandro J; Chanez, Brice; Madroszyk, Anne; Olive, Daniel; Garon, Edward B

Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung Trial

来自 SAFIR02-Lung 试验的晚期非小细胞肺癌患者的体细胞和种系 BRCA 1 和 2 突变

Remon, Jordi; Besse, Benjamin; Leary, Alexandra; Bièche, Ivan; Job, Bastien; Lacroix, Ludovic; Auguste, Aurélie; Mauduit, Marjorie; Audigier-Valette, Clarisse; Raimbourg, Judith; Madroszyk, Anne; Michels, Stefan; Bayar, Mohammed Amine; Jimenez, Marta; Soria, Jean-Charles; Rouleau, Etienne; Barlesi, Fabrice